Every night, the online Belgian patent register ('eRegister') receives an update with public data that were entered or generated the preceding day on the Benelux Patent Platform, the computer application with which the Belgian Intellectual Property Office handles the registration, treatment and publication processes for patents and supplementary protection certificates.
Currently, some updates are spread over consecutive nights due to the large, weekly volume of data concerning European patents designating Belgium.
For a European patent it is possible that data about the inventor(s) are missing from the online Belgian patent register. They can be found via the link to the European patent register pending an update of the Belgian patent register.
For European patents with Unitary Effect, the authentic source of information is the European Patent Register : please refer to it.

Patent details

3789389 Title: CRISTALLINE FORME DE (S)-N-[5-[1-(3-ÉTHOXY-4-MÉTHOXYPHÉNYL)-2-(MÉTHYLSULFONYL)ÉTHYL]-4,6-DIOXO-5,6-DIHYDRO-4H-THIÈNO[3,4-C]PYRROLE-1-YL]ACÉTAMIDE

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic information

Application number:
197971435
WO application number:
CN2019085327
Type:
European patent granted for BE
Status:
Open
Publication number:
3789389
WO publication number:
WO2019210864
1rst applicant's nationality:
Translation language:
EPO publication language:
English
SPC number:

Dates

Filing date:
30/04/2019
Grant date:
08/10/2025
EP publication date:
10/03/2021
WO publication date:
07/11/2019
Claims translation received date:
Translation received date (EP publication B1):
Translation received date (EP publication B2):
Translation received date (EP publication B3):
Registration date:
08/10/2025
EP B1 publication date:
08/10/2025
EP B2 publication date:
EP B3 publication date:
Lapsed date:
Expiration date (if granted and all annual fees paid):
30/04/2039

Applicant

Name:
Tianjin Hemay Pharmaceutical Co., Ltd.
Legal Form:
From:
08/10/2025
Address:
Bld. 12-2, Hui-Ying-Chan-Ye-Yuan No. 86 Zhong-Huan West Road Free Trade Zone (Airport Economic Area) Dongli District, Tianjin 300308, China (CN)
To:

Agent

Name:
CABINET BEDE
Legal Form:
From:
09/10/2025
Address:
Boulevard Général Wahis 15, 1030, BRUXELLES, Belgium (BE)
To:

Inventor

1

Name:
ZHANG, Donglei
Legal Form:
Address:
Tianjin 300308, China (CN)

2

Name:
WANG, Liyu
Legal Form:
Address:
Tianjin 300308, China (CN)

3

Name:
CHANG, Yukun
Legal Form:
Address:
Tianjin 300308, China (CN)

Priority

Priority patent number:
201810407741
Priority date:
02/05/2018
Priority country:
China (CN)

Classification

IPC or IDT classification:
C07D 495/04; A61K 31/407; A61P 1/00; A61P 1/04; A61P 11/00; A61P 11/06; A61P 17/00; A61P 17/06; A61P 19/00; A61P 19/02; A61P 19/08; A61P 19/10; A61P 29/00; A61P 31/00; A61P 31/18; A61P 35/00; A61P 37/00; A61P 37/02; A61P 37/06;

Publication

Bulletin

Bulletin heading:
EP2
Journal edition number:
2025/19
Publication date:
08/12/2025
Description:
Contains data concerning European patents granted and published (B1 publication) for Belgium and for which no translation needed to be filed

European Patent Bulletin

Issue number:
202541
Publication date:
08/10/2025
Description:
Grant (B1)

Annual fee

Annual fee(s) Due Date:
30/04/2026
Annual fee number:
8
Annual fee amount:
135 Euro
Expected payer:
Last annual fee payment date:
Last annual fee paid number:
Payer:
Filing date Document type Publication Type Document Description Number of pages File Type
09/10/2025 Incoming Correspondence (Post) 1 PDF /7/8/3/8/8/0722588387/docs/197971435_0_incomingcorrespondencepaper_20251010_083230854.pdf